INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.91
-0.01
(-1.61%)
Pre-Market: 08:41
INVO Bioscience Gross Profit Margin (Quarterly): 35.82% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.82% |
| September 30, 2023 | 40.41% |
| June 30, 2023 | 19.15% |
| March 31, 2023 | 79.15% |
| December 31, 2022 | 15.66% |
| September 30, 2022 | -5.80% |
| June 30, 2022 | -31.80% |
| March 31, 2022 | 60.05% |
| December 31, 2021 | 98.45% |
| September 30, 2021 | 90.67% |
| June 30, 2021 | 93.00% |
| March 31, 2021 | 90.83% |
| December 31, 2020 | 94.81% |
| September 30, 2020 | 91.85% |
| June 30, 2020 | 91.40% |
| March 31, 2020 | 88.40% |
| December 31, 2019 | 91.33% |
| September 30, 2019 | 85.20% |
| June 30, 2019 | 91.61% |
| March 31, 2019 | 94.20% |
| December 31, 2018 | 71.70% |
| September 30, 2018 | 87.71% |
| June 30, 2018 | 84.84% |
| March 31, 2018 | 86.15% |
| Date | Value |
|---|---|
| December 31, 2017 | 86.37% |
| September 30, 2017 | 81.20% |
| June 30, 2017 | 82.33% |
| March 31, 2017 | 73.50% |
| December 31, 2016 | 67.50% |
| September 30, 2016 | 63.80% |
| June 30, 2016 | 56.26% |
| March 31, 2016 | 82.52% |
| December 31, 2015 | |
| September 30, 2015 | -75.57% |
| June 30, 2015 | |
| March 31, 2015 | 39.09% |
| December 31, 2011 | 45.43% |
| September 30, 2011 | 74.69% |
| June 30, 2011 | 70.79% |
| March 31, 2011 | 81.17% |
| December 31, 2010 | 72.32% |
| September 30, 2010 | |
| June 30, 2010 | 67.84% |
| March 31, 2010 | 68.97% |
| December 31, 2009 | -57.30% |
| September 30, 2009 | -29.10% |
| June 30, 2009 | 62.86% |
| March 31, 2009 | 43.86% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-31.80%
Minimum
Jun 2022
98.45%
Maximum
Dec 2021
64.22%
Average
88.40%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 55.21% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
| Catheter Precision Inc | 94.53% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -70.16% |
| Return on Invested Capital | -563.4% |
| Profit Margin (Quarterly) | -144.4% |
| Operating Margin (Quarterly) | -109.2% |
| Return on Net Operating Assets | -84.14% |